Publications by authors named "Paola Tarchi"

Claim this Profile
A
An organotypic model of ductular reaction reveals a mevalonate-dependent vulnerability in reactive biliary cells.
Beatrice Anfuso, Suresh Velnati, Davide Selvestrel, Clara Garlant, Elisa Ferracci, Paola Tarchi

Cell Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying the risk in liver surgery: performance in an Italian cohort of 3.280 liver resection for HCC.
Guido Costa, Matteo Donadon, Federica Cipriani, Matteo Serenari, Francesco Ardito, Paola Tarchi

HPB (Oxford)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive hepatectomy thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison.
Felice Giuliante, Simone Famularo, Sara Grasselli, Angelo Sangiovanni, Alessandro Vitale, Paola Tarchi

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
Loraine Kay Cabral, Cyrollah Disoma, Paola Tarchi, Korri Elvanita El-Khobar, Agustiningsih Agustiningsih

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysis.
Gianluca Cassese, Mariano C Giglio, Alessandro Vitale, Andrea Lauterio, Matteo Serenari, Paola Tarchi

HPB (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national register.
Simone Famularo, Flavio Milana, Francesco Ardito, Federica Cipriani, Alessandro Vitale, Paola Tarchi

HPB (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
Alessandro Vitale, Pierluigi Romano, Umberto Cillo, , , Paola Tarchi

JAMA Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysis.
Mattia Garancini, Matteo Serenari, Simone Famularo, Federica Cipriani, Francesco Ardito, Paola Tarchi

Langenbecks Arch Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario.
Simone Famularo, Umberto Cillo, Andrea Lauterio, Matteo Donadon, Alessandro Vitale, Paola Tarchi

HPB (Oxford)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the ACS-NSQIP Surgical Risk Calculator in Patients with Hepatic Metastases from Colorectal Cancer Undergoing Liver Resection.
Tommaso Campagnaro, Edoardo Poletto, Paola Tarchi, Simone Rattizzato, Giuseppe Verlato

J Gastrointest Surg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of preoperative albumin-bilirubin score and other risk factors for short-term outcomes after open pancreatoduodenectomy.
Hana Zavrtanik, Davide Cosola, David Badovinac, Benjamin Hadžialjević, Gašper Horvat, Paola Tarchi

World J Clin Cases· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis.
Matteo Serenari, Jacopo Lenzi, Alessandro Cucchetti, Federica Cipriani, Matteo Donadon, Paola Tarchi

Ann Surg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Simone Famularo, Matteo Donadon, Federica Cipriani, Federico Fazio, Francesco Ardito, Paola Tarchi

JAMA Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience.
Mauro Giuffrè, Enrico Zuliani, Alessia Visintin, Paola Tarchi, Paola Martingano

Diagnostics (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group.
Maurizio Iaria, Giorgio Bianchi, Federico Fazio, Francesco Ardito, Pasquale Perri, Paola Tarchi

HPB (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort.
Simone Famularo, Nadia Russolillo, Matteo Donadon, Federica Cipriani, Francesco Ardito, Paola Tarchi

HPB (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
Simone Conci, Federica Cipriani, Matteo Donadon, Ivan Marchitelli, Francesco Ardito, Paola Tarchi

Eur J Surg Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study.
Simone Famularo, Matteo Donadon, Federica Cipriani, Francesco Ardito, Maurizio Iaria, Paola Tarchi

J Gastrointest Surg· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations.
An B Luong, Huy Q Do, Paola Tarchi, Deborah Bonazza, Cristina Bottin

Cells· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma.
Alessandro Giani, Federica Cipriani, Simone Famularo, Matteo Donadon, Davide P Bernasconi, Paola Tarchi

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Von Meyenburg complexes: a rare intrahepatic bile duct malformation.
Paola Tarchi, Chiara Di Renzo, Parissa Tabrizian, Chiara Rocha, Myron E Schwartz

Minerva Chir· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience.
Simone Famularo, Matteo Donadon, Federica Cipriani, Francesco Ardito, Francesca Carissimi, Paola Tarchi

Updates Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma.
Caecilia H C Sukowati, Riccardo Patti, Devis Pascut, Rusdina B Ladju, Paola Tarchi

Biomed Res Int· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma.
Paola Tarchi, Parissa Tabrizian, Jake Prigoff, Myron Schwartz

Surgery· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients With Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation Therapy.
Zahra Ghiassi-Nejad, Paola Tarchi, Erin Moshier, Meng Ru, Parissa Tabrizian

Int J Radiat Oncol Biol Phys· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis